{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:08:28Z","timestamp":1792602508860,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Liver cancer is one of the leading causes of cancer-related deaths worldwide. In Europe, viral hepatitis, alcohol consumption, and metabolic diseases contribute to this burden. Using data from the Global Burden of Disease Study 2021, we report here the liver cancer epidemiology in Europe between 1990 and 2021, describing recent trends, geographical disparities, and the major risk factors influencing disease outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The Global Burden of Disease Study 2021 provided standardized data on liver cancer incidence, mortality, and disability-adjusted life years (DALYs) across Europe from 1990 to 2021, utilizing advanced statistical modeling tools like DisMod-MR 2.1 to ensure accuracy and comparability. Age-standardized rates (age-standardized incidence rate, ASIR; age-standardized mortality rate (ASMR); and age-standardized DALYs rate, ASDR) were analyzed alongside the socio-demographic Index (SDI) to evaluate trends, regional disparities, and associations using joinpoint regression and LOESS modeling. Data visualization involved Python tools, including choropleth maps and regression plots.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Liver cancer burden in Europe has increased significantly, with the ASIR rising from 3.04 [2.93\u20133.14] in 1990 to 4.20 [3.93\u20134.40] in 2021, the ASMR increasing from 3.08 [2.96\u20133.18] to 3.86 [3.59\u20134.05], and the ASDR rising from 78.48 [76.09\u201380.74] to 91.43 [86.48\u201395.79]. Males consistently showed higher rates than females, and older populations bore the highest burden, with deaths and DALYs peaking in the 95+\u00a0age group in 2021. Nationally, Andorra reported the highest ASIR, ASMR, and ASDR in 2021, while Ukraine had the lowest rates. Hepatitis C and alcohol-related liver cancer were the leading contributors, with NASH showing the fastest growth. Regions with higher SDI demonstrated greater burden, highlighting healthcare access and detection disparities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Liver cancer burden in Europe is driven by rising obesity, aging populations, lifestyle changes, and healthcare disparities, with incidence and mortality growing faster in the Europe, especially the Western region. Comprehensive strategies focusing on prevention, early detection, and equitable access to care are essential.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003433","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:00:09Z","timestamp":1748527209000},"page":"4053-4065","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Burden of liver cancer in the European region from 1990 to 2021: a sub-analysis of the global burden of disease study"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6658-7483","authenticated-orcid":false,"given":"Onika","family":"Kazi","sequence":"first","affiliation":[{"name":"School of Medicine, Shahid Beheshti University of Medical University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3222-1072","authenticated-orcid":false,"given":"Shokoufeh","family":"Hamidzadeh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6354-7031","authenticated-orcid":false,"given":"Babak","family":"Ehsani Zunuz","sequence":"additional","affiliation":[{"name":"School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7612-2155","authenticated-orcid":false,"given":"Abdolsabour","family":"Khordoo","sequence":"additional","affiliation":[{"name":"School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Hormozgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7784-6946","authenticated-orcid":false,"given":"Seyede Saba","family":"Mazloomi","sequence":"additional","affiliation":[{"name":"School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Hormozgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1009-4678","authenticated-orcid":false,"given":"Hossein","family":"Khademsedaghat","sequence":"additional","affiliation":[{"name":"School of Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-8617","authenticated-orcid":false,"given":"Mohammad Amin","family":"Khadembashiri","sequence":"additional","affiliation":[{"name":"School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Neuromusculoskeletal Research Center, Firozgar Hospital, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"R1-20250922","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"key":"R2-20250922","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/add.13757","article-title":"The relationship between different dimensions of alcohol use and the burden of disease-an update","volume":"112","author":"Rehm","year":"2017","journal-title":"Addiction"},{"key":"R3-20250922","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12933-020-01052-1","article-title":"Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity","volume":"19","author":"Bendor","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"R4-20250922","doi-asserted-by":"crossref","first-page":"e1003100","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"key":"R5-20250922","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"R6-20250922","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg"},{"key":"R7-20250922","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhep.2023.12.031","article-title":"Inequities in primary liver cancer in Europe: the state of play","volume":"80","author":"Kondili","year":"2024","journal-title":"J Hepatol"},{"key":"R9-20250922","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.21037\/jgo.2020.02.08","article-title":"Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management","volume":"12","author":"Samant","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"R10-20250922","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"R11-20250922","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R12-20250922","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study; 2021","volume":"403","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"R14-20250922","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"R15-20250922","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Murray","year":"2020","journal-title":"Lancet"},{"key":"R16-20250922","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2019-216515","article-title":"Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the global burden of disease study 2017","volume":"79","author":"Safiri","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R17-20250922","doi-asserted-by":"crossref","first-page":"28131","DOI":"10.1038\/s41598-024-77658-2","article-title":"Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data","volume":"14","author":"Guo","year":"2024","journal-title":"Sci Rep"},{"key":"R18-20250922","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3350\/cmh.2023.0070","article-title":"The latest global burden of liver cancer: a past and present threat","volume":"29","author":"Oh","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R19-20250922","first-page":"679","article-title":"Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends","volume":"21","author":"Cao","year":"2024","journal-title":"Cancer Biol Med"},{"key":"R20-20250922","doi-asserted-by":"crossref","first-page":"19544","DOI":"10.1038\/s41598-024-70526-z","article-title":"Changes in the epidemiological trends of primary liver cancer in the asia-pacific region","volume":"14","author":"Danpanichkul","year":"2024","journal-title":"Sci Rep"},{"key":"R21-20250922","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17998\/jlc.2024.03.13","article-title":"Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide","volume":"24","author":"Kim","year":"2024","journal-title":"J Liver Cancer"},{"key":"R22-20250922","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.7150\/jca.52282","article-title":"Age, gender and geographic differences in global health burden of cirrhosis and liver cancer due to nonalcoholic steatohepatitis","volume":"12","author":"Zhang","year":"2021","journal-title":"J Cancer"},{"key":"R23-20250922","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"R24-20250922","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/CM9.0000000000003264","article-title":"Global epidemiology of liver cancer 2022: an emphasis on geographic disparities","volume":"137","author":"Li","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R25-20250922","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.32758","article-title":"Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH","volume":"77","author":"Tan","year":"2023","journal-title":"Hepatology"},{"key":"R26-20250922","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/CEJ.0000000000000428","article-title":"Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors","volume":"27","author":"Baecker","year":"2018","journal-title":"Eur J Cancer Prev"},{"key":"R27-20250922","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"2021","journal-title":"Eur J Cancer"},{"key":"R28-20250922","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R29-20250922","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/lci2.77","article-title":"Geographic and temporal trends in aetiology, incidence and mortality from hepatocellular carcinoma in European Union 15+ countries","volume":"4","author":"Hanbury","year":"2023","journal-title":"Liver Cancer Int"},{"key":"R30-20250922","first-page":"404","article-title":"Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis","volume":"34","author":"Cholongitas","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"R31-20250922","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T07:02:15Z","timestamp":1758524535000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003433","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"2025-01-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}